Trials / Unknown
UnknownNCT03807570
Efficacy and Safety Morus Alba L. Extract on Improvement of Blood Flow
A 12 Weeks, Randomized, Double-blind, Placebo-controlled Human Trial to Evaluate the Efficacy and Safety Morus Alba L. Extract on Improvement of Blood Flow
- Status
- Unknown
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 100 (estimated)
- Sponsor
- Chonbuk National University Hospital · Academic / Other
- Sex
- All
- Age
- 50 Years – 75 Years
- Healthy volunteers
- Accepted
Summary
The effect of 12 weeks intake of Morus alba L. on blood circulation improvement and related indicators is assessed compared to placebo intake.
Detailed description
This study was a 12 weeks, randomized, double-blind, placebo-controlled human trial. Hundred subjects were randomly divided into Morus alba L. extract or a placebo group. Blood was collected and changes in blood circulation related indicators were observed.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DIETARY_SUPPLEMENT | Morus Alba L. Extract | Morus Alba L. Extract 30 ml/day for 12 weeks. |
| DIETARY_SUPPLEMENT | Placebo | Placebo 30 ml/day for 12 weeks. |
Timeline
- Start date
- 2018-11-12
- Primary completion
- 2021-01-30
- Completion
- 2021-01-31
- First posted
- 2019-01-17
- Last updated
- 2020-05-08
Locations
1 site across 1 country: South Korea
Source: ClinicalTrials.gov record NCT03807570. Inclusion in this directory is not an endorsement.